BioAdaptives Inc (BDPT)

[Diligence Due]

Dd Package below:

AI weight loss and wellness app partnership:

https://www.globenewswire.com/en/news-release/2023/03/23/2633080/0/en/BioAdaptives-Announces-Signing-of-Letter-of-Intent-With-World-Wellness-LLC-for-the-Launching-of-Weight-Management-System-Including-an-AI-Supported-Body-Composition-Measuring-App-an.html

“FIT YOUR OUTFIT (FYO) app that utilized AI to scientifically measures body composition with a single photo from a smartphone with outstanding concordance and accuracy compared to the gold standard reference DXA.”

New board of directors, all A list members

Dr. Yaguang Liu (Mr. patent)

https://www.globenewswire.com/en/news-release/2023/04/05/2641625/0/en/BioAdaptives-Inc-OTC-BDPT-Announces-New-Appointment-to-the-Board-of-Directors-Internationally-Acclaimed-Health-Scientist-Author-and-Patent-Holder-Dr-Yaguang-Liu.html

“Yaguang Liu is the founder of L.Y. Research Corporation located in New Jersey. He has received 32U.S. patents of pure and safe natural botanicals, used for treatment of cancer and cardiovascular and other diseases”

Dr. David Allen (Marketing and AI Specialist)

https://www.globenewswire.com/en/news-release/2023/04/13/2646145/0/en/BioAdaptives-Inc-OTC-BDPT-Announces-New-Appointment-to-the-Board-of-Directors-Visionary-Futurist-Wellness-Pioneer-and-Marketer-David-Allen-PhD.html

“He has more than 30 years of experience developing and marketing wellness products in North America, Europe, and Asia. As we expand globally with new products, we anticipate that Dr. Allen’s expertise in the utilization of emerging AI technologies and botanical drugs will be especially valuable”

Patent Licenses:

https://finance.yahoo.com/news/bioadaptives-inc-announced-today-signing-120000274.html

https://finance.yahoo.com/news/bioadaptives-signs-non-exclusive-license-120000032.html

https://finance.yahoo.com/news/bioadaptives-signs-non-exclusive-license-120000157.html

Yes, they don’t own the patents worth nearly 1 BILLION dollars, but the licenses open the door for dozens of millions in revenue per year. The value of these licenses alone makes this a .01-.04 stock

Livestock Spinoff

https://www.globenewswire.com/en/news-release/2023/04/20/2650937/0/en/BioAdaptives-Inc-Announces-Intention-to-Spin-off-Its-Livestock-Impact-Division-as-a-Wholly-owned-Subsidiary-With-Further-Expansion-in-Botanical-Drug-Development-and-Animal-Health-M.html

“will expand its activities globally to include botanical drugs for both veterinary and human use.

According to Straits Research, “The global botanical drug market size was valued at USD 163 million in 2021 and is expected to be valued at USD 3221 million by 2030”

Last BUT not least, the dilution

I would refer you to PowerBattles posts, but I know people tend to be lazy so I’ll break it down quickly. 100+ million shares were issued to 1800, those shares are done being sold. OS unchanged yesterday. Go check PB’s posts for a full breakdown

This Stock still sits under 600M OS and a market cap under a million. With everything going on this stock should be 10+M market cap at a minimum. Grab some gifts down here and enjoy the penny run. I know I will (: